Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc, a global leader in consumer health, covers the month of September 2024. The report specifically details a transaction in the company's own shares executed on September 2, 2024, under a share buyback programme announced on August 1, 2024.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. It focuses exclusively on share repurchase activity. Key transaction data includes:
- Shares Purchased: 208,352 ordinary shares
- Price Range: Lowest 380.10p, Highest 382.70p
- Volume Weighted Average Price: 381.5830p
- Post-Transaction Share Capital: 9,123,430,592 ordinary shares
Material Changes
The primary material change reported is the reduction of the company's registered share capital following the cancellation of the 208,352 shares purchased. No other material changes to financial position or operations are disclosed in this specific filing.
Guidance, Outlook, and Risks
This filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It is a regulatory disclosure of a specific share transaction required under the Market Abuse Regulation (Article 5s(1)(b)).
Investor Verification Checklist
- Verify the total number of shares repurchased under the August 2024 Buyback Programme to date.
- Confirm the current market price of Haleon shares relative to the 381.5830p average purchase price.
- Review the full trade breakdown available via the provided London Stock Exchange link for granular transaction timing.
- Check subsequent filings for updates on the remaining authorized buyback capacity.